Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
01/2003
01/23/2003WO2003005965A2 Modulators of ceramidase and methods of use based thereon
01/23/2003US20030018056 Sodium channel moderators; cardiovascular disorders; antidiabetic agents
01/23/2003US20030018032 Bicyclic imidazo-3-yl-amine derivatives
01/23/2003US20030018013 Cardiovascular disorders; antilipemic agents; Alzheimer's disease
01/23/2003DE19964298C2 Preparation of substituted arylhalophosphines for use in tertiary phosphine ligand catalysis
01/23/2003CA2452513A1 Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound
01/22/2003EP1277758A1 Phosphorus compound
01/22/2003EP1277741A1 Cyclic compounds
01/22/2003EP1276744A1 N-alpha , n-omega -dialkyl aminomethylenephosphonic acids and use thereof
01/22/2003EP1276743A1 Ion liquids derived from lewis acid based on titanium, niobium, tantalum, tin or antimony, and uses thereof
01/22/2003EP1276727A1 Novel amino carboxy alkyl derivatives of barbituric acid
01/22/2003EP1235828A4 Process and intermediates to a tetrahydro-[1,8]-naphthyridine
01/22/2003EP1212134A4 Metallacrown ether catalysts for hydroformylation
01/22/2003EP1147100A4 Recovery of chroman derivatives
01/22/2003EP1140953B1 Method of purifying thiamine phosphates
01/22/2003EP1119574B1 Substituted isophosphindolines and their use
01/22/2003EP1000006B1 Improved process of preparation of linear aldehydes
01/22/2003EP0970093B1 Aluminium salts of alkylhydroxymethylphosphinic acids
01/22/2003EP0952978B1 Metallocenes and catalysts for olefin-polymerisation
01/22/2003CN1392876A Combretastatin A-4 phosphate prodrug, mono-and di-organic amine salt, mono-and di-amino acids salts, and mono-and di-amino acid ester salt
01/22/2003CN1392152A Process for purifying phosphonium salt
01/22/2003CN1099422C Catalyst component compound and its preparing method and use
01/22/2003CN1099420C Substituted spiroheterocyclic 1H-3-arylpyrrolidine-2-4,-dione derivatives, methods of preparing them and their use as pest-control agents
01/21/2003US6509507 Polymerizable biaryls, process for their preparation and their use
01/21/2003US6509505 Hydrogenation catalysts
01/21/2003US6509334 Cyclocarbamate derivatives as progesterone receptor modulators
01/21/2003US6509324 Use as contrast agents in magnetic resonance imaging
01/21/2003US6509110 Triptycene derivatives and their use for opto-electronics applications, in particular as electroluminescent materials
01/21/2003US6508753 Chiral ligands for asymmetric catalysis
01/16/2003WO2003004512A1 Activators for oligonucleotide synthesis
01/16/2003WO2003004506A1 Non-metallocenes, method for the production thereof and use thereof in the polymerization of olefins
01/16/2003WO2003004446A1 Process for producing fluorinated alcohol
01/16/2003WO2003004157A2 Optically active catalysts containing a salen ligand and vanadium (iv), production thereof and use of the same for producing cyanohydrins
01/16/2003WO2001092354A3 Copolymers of ethylene and selected acrylate esters
01/16/2003WO2001092347A3 Polymerization of olefins
01/16/2003WO2001092342A3 Catalysts for olefin polymerization
01/16/2003US20030013918 Reacting a carbonyl compound with a phosphorus halide in a carrier/solvent system (which consists of an amine hydrochloride, a phosphorus acid) to produce a bisphosphonate
01/16/2003US20030013861 E-isomeric fullerene derivatives
01/16/2003US20030013859 Use as contrast agents in magnetic resonance imaging
01/16/2003US20030013837 Method for producing phosphonium phenolates
01/16/2003US20030013772 Composition, synthesis and therapeutic applications of polyamines
01/16/2003US20030013698 Vanadium (IV) complexes containing catecholate ligand and having spermicidal activity
01/16/2003US20030013685 Process for increasing the egg production and strengthening the eggshells of poultry
01/16/2003US20030013677 Anticancer agents
01/16/2003US20030013660 Dioxolane analogs for improved inter-cellular delivery
01/16/2003US20030012827 May be administered in a purified form, or as part of a larger molecule, such as a glyceride that may be mixed, which releases free fatty acid after ingestion
01/16/2003US20030012720 Dehydrating washed rice bran under pressure and drying; burning at a first temperature of 350-400 degrees C. while agitating and pulverizing and burning at a second temperature of 700-1000 degrees C. for 10 60 minutes
01/15/2003EP1275301A1 Trisubstituted heterocyclic compounds and their use as fungicides
01/15/2003EP1274879A1 A process for the purification of organometallic compounds or heteroatomic organic compounds with hydrogenated getter alloys
01/15/2003EP1274744A2 Polymer-supported synthesis of heteroatom bidentate ligands for catalysis
01/15/2003EP1274738A2 Polymerizable compounds and uses thereof
01/15/2003EP1274469A2 Native protein mimetic fibers, fiber networks and fabrics for medical use
01/15/2003EP1070074B1 Phosphorus compounds as corrosion inhibitors for perfluoropolyethers
01/15/2003EP0983281B1 Method for producing aluminium salts of cyclic phosphinic acids
01/15/2003EP0975426B1 Method for producing silasesquioxane metal complexes, novel silasesquioxane metal complexes and the use thereof
01/15/2003EP0970094B1 Process for purifying neomenthyldiphenylphosphines using methanol
01/15/2003EP0885232B1 Novel 1(2h) quinoline carboxylic acid derivatives, method for preparing same, and use thereof for synthesising substances having antibiotic properties
01/15/2003EP0754178B1 Novel functionalized hydrophilic acridinium esters
01/15/2003EP0722442B1 Polyazacycloalkanes as dichelants
01/15/2003CN1391573A Bicyclic imidazo-3-yl-amine derivatives
01/15/2003CN1391562A Quinazoline derivatives as pharmaceuticals
01/15/2003CN1391542A C13 alcohol mixture and functionalized C13 alcohol mixture
01/15/2003CN1390844A Process for preparing 3-(biethoxyphosphacyloxy)-4-oxo-1,2,3-henzotriazine
01/15/2003CN1390843A process for extracting phosphatidecholine from powdered soybean phosphatide
01/15/2003CN1390842A Phosphonic choline containing hydroxy, its preparing process and process for preparing biological material containing it
01/15/2003CN1098856C amidophosphinephosphinite compounds
01/14/2003US6506934 Compounds particularly useful as antifoggants in silver halide photographic materials
01/14/2003US6506915 Stereospecific synthesis of optically pure trans (E)isomer of coenzyme Q10 starting from geranyl bromide and 2,3,4,5-tetramethoxytoluene
01/14/2003US6506894 Solution phase synthesis of oligonucleotides
01/14/2003US6506804 Ethylenically unsaturated amine salts of sulfonic, phosphoric, and carboxylic acids
01/14/2003US6506799 Treating or preventing a cardiovascular disease in a patient, comprising administering to a patient in need of such treatment or prevention a therapeutically effective amount of 6-(6-hydroxy-5,5-dimethylhexyloxy)-2,2-dimethyl-hexan-1-ol and
01/14/2003US6506739 Compounds possess anti-tumor activities or are capable of being modified to have anti-tumor activities; and this invention relates to the use of the compounds in methods for the treatment of tumors and, especially, for the treatment of
01/14/2003US6506738 Treatment of viral infections. More particularly, the invention provides benzimidazolone derivatives for the treatment of respiratory syncytial virus infection.
01/14/2003US6506517 Surface modified carbonaceous materials
01/09/2003WO2003002974A2 Ecl labels having improved non-specific binding properties, methods of using and kits containing the same
01/09/2003WO2003002581A1 Process for the production of pentaerythritol phosphate alcohol
01/09/2003WO2003002580A1 6-`2-(phosphonomethoxy)alkoxy pyrimidine derivatives having antiviral activity
01/09/2003WO2003002579A1 Novel strong acids, production method and uses thereof
01/09/2003WO2003002118A1 Substituted 8-arylquinoline pde4 inhibitors
01/09/2003WO2002070529A3 Method of making phosphorus-containing compounds and products thereof
01/09/2003WO2002007669A3 Phospholipid derivatives of valproic acid and mixtures thereof
01/09/2003WO2001098294A3 Vitronectin receptor antagonist pharmaceuticals for use in combination therapy
01/09/2003US20030009036 To produce polymers; cancer therapy
01/09/2003US20030008891 Substituted 3',4' -Di-O-camphanoyl-(+)-cis-khellactone analogs, compositions thereof, and methods for using thereof
01/09/2003US20030008850 For therapy and prophylaxis of cancer
01/09/2003US20030008849 For therapy of diseases mediated by TNF- alpha , such as rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis, multiple sclerosis, Crohn's disease and degenerative cartilage loss
01/09/2003US20030008304 Fluorescent quenching detection reagents and methods
01/09/2003US20030006398 Optically active compound, photoreactive chiral agent, liquid crystal composition, method for changing helical structure of liquid crystal, method for fixing helical structure of liquid crystal, liquid crystal color filter, optical film, and recording medium
01/09/2003CA2450686A1 Substituted 8-arylquinoline pde4 inhibitors
01/09/2003CA2448043A1 Novel strong acids, process for the preparation thereof, and uses thereof
01/08/2003EP1273584A1 2- or 4-Chromenyliden based merocyanines and use thereof
01/08/2003EP1272501A1 Process for the preparation of phosphorothioate triesters
01/08/2003EP1272498A1 Removal of chloride from phosphonomethyliminodiacetic acid process
01/08/2003EP1272497A1 Phosphorus containing materials, their preparation and use
01/08/2003EP1272451A2 Process and catalyst for dehydrogenating primary alcohols to make carboxylic acid salts
01/08/2003EP1272237A1 Antithrombogenic membrane mimetic compositions and methods
01/08/2003EP1272198A1 Use of organophosphorous compounds for producing a medicament for treating infections
01/08/2003EP1124833B1 Diphosphines
01/08/2003EP1107947B1 Method for producing cyanovaleric acid or esters thereof
01/08/2003EP0981531B1 Formation of 1-phenylvinyl-1-phosphonic acid